Disclosure 0001104659-26-106831-2

SEC FORM 4

$7,902,361.38

Protagonist Therapeutics, Inc (PTGX)

Sale of 54,174 shares at $145.87 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Protagonist Therapeutics, Inc (PTGX)." Disclosed 2026-09-10. https://desqlong.com/cards/0001104659-26-106831-2 (retrieved 2026-09-26).